Synopsys Q3 Preview: Strengthening EDA And Simulation In HPC AI Chips

An analyst reiterates a Sell rating on Synopsys (SNPS) with a $459 fair value, citing overvaluation despite recent positive developments. These include the completion of its $35 billion Ansys acquisition, strong Q2 FY25 results with 10.3% revenue growth driven by leadership in HPC AI chips, and the recent rescinding of US export restrictions to China, which could lead to raised FY25 guidance. While acknowledging Synopsys's strong market position and AI-driven growth, the analyst maintains the stock is overvalued.

Analysis

Despite a series of positive developments, the primary thesis for Synopsys, Inc. (SNPS) remains centered on overvaluation, leading to a reiterated Sell rating with a $459 fair value target. Operationally, the company demonstrates significant strength, having completed its $35 billion acquisition of Ansys, a key strategic milestone for integrating EDA and simulation platforms and expanding into new industrial and aerospace markets. This is reinforced by a strong Q2 FY25 performance, where revenue grew 10.3% and operating profit increased 12.2%, beating expectations. Growth was largely driven by Synopsys's critical market position in HPC AI chips, underscored by management's commentary on its 3DIC Compiler technology. A major near-term catalyst is the U.S. Department of Commerce's decision to rescind prior export restrictions to China, which accounts for approximately 10% of revenue. This policy change is expected to push Synopsys toward the high end of its Q3 guidance and may lead to a full-year guidance raise. However, these positive factors are weighed against a valuation that the analyst's Discounted Cash Flow (DCF) model, using a 10.2% WACC and 6% terminal growth rate, deems excessive.

Key Decisions for Investors

• Investors with long positions should consider the significant discrepancy between the current market price and the analyst's $459 fair value target, which suggests a valuation risk despite strong fundamentals and recent positive catalysts.
• Monitor the Q3 FY25 earnings release on September 9th for any upward revision to full-year guidance, as the recent lifting of US export restrictions for China could provide a near-term upside surprise that challenges the bearish thesis.
• Long-term investors should track the synergy realization from the Ansys acquisition and the sales trajectory of new hardware platforms like HAPS-200, as outperformance in these areas could be crucial to justifying the stock's current premium.
• Given the ongoing geopolitical tensions, any signs of renewed challenges in the China market should be considered a key risk factor, potentially impacting the ~10% of revenue derived from the region.